AnorMED Report issue

Contributed to NME For profit Phase 2
Founded: Vancouver Canada (1996)
Status: Acquired by Genzyme (2006) → now Sanofi-Aventis (2011)

Organization Overview

First Clinical Trial
2004
NCT00322491
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2006

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree